Xiaochang Liu

628 total citations
32 papers, 471 citations indexed

About

Xiaochang Liu is a scholar working on Pharmaceutical Science, Molecular Biology and Immunology. According to data from OpenAlex, Xiaochang Liu has authored 32 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 7 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Xiaochang Liu's work include Advancements in Transdermal Drug Delivery (9 papers), Advanced Drug Delivery Systems (6 papers) and Nanoplatforms for cancer theranostics (3 papers). Xiaochang Liu is often cited by papers focused on Advancements in Transdermal Drug Delivery (9 papers), Advanced Drug Delivery Systems (6 papers) and Nanoplatforms for cancer theranostics (3 papers). Xiaochang Liu collaborates with scholars based in China and South Korea. Xiaochang Liu's co-authors include Liang Fang, Peng Quan, Yang Chen, Manli Wang, Qiao Mei, Jianming Xu, Yongshan Zhao, Yuan Zhao, Chao Liu and Shanshan Li and has published in prestigious journals such as The Science of The Total Environment, Langmuir and Journal of Agricultural and Food Chemistry.

In The Last Decade

Xiaochang Liu

30 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaochang Liu China 14 212 102 68 54 44 32 471
Giulia Vanti Italy 13 173 0.8× 140 1.4× 33 0.5× 92 1.7× 22 0.5× 29 562
M. Moshahid Alam Rizvi India 10 232 1.1× 156 1.5× 75 1.1× 75 1.4× 60 1.4× 19 639
Ji–Hyun Kang South Korea 16 197 0.9× 151 1.5× 52 0.8× 96 1.8× 19 0.4× 51 699
Gehan F. Balata Egypt 13 316 1.5× 105 1.0× 29 0.4× 67 1.2× 47 1.1× 30 527
Farhat Fatima Saudi Arabia 18 321 1.5× 140 1.4× 46 0.7× 92 1.7× 61 1.4× 43 773
Won Seok Lee South Korea 10 258 1.2× 81 0.8× 144 2.1× 37 0.7× 34 0.8× 21 560
Ling-Chun Chen Taiwan 14 170 0.8× 165 1.6× 29 0.4× 70 1.3× 51 1.2× 22 606
Manal A Elsheikh Egypt 12 124 0.6× 123 1.2× 45 0.7× 29 0.5× 15 0.3× 19 450
Vikas Jhawat India 13 207 1.0× 133 1.3× 29 0.4× 40 0.7× 43 1.0× 57 503
Nicholas Farrell United States 8 131 0.6× 114 1.1× 54 0.8× 18 0.3× 25 0.6× 15 526

Countries citing papers authored by Xiaochang Liu

Since Specialization
Citations

This map shows the geographic impact of Xiaochang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochang Liu more than expected).

Fields of papers citing papers by Xiaochang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaochang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochang Liu. The network helps show where Xiaochang Liu may publish in the future.

Co-authorship network of co-authors of Xiaochang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaochang Liu. A scholar is included among the top collaborators of Xiaochang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaochang Liu. Xiaochang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Xiaochang, et al.. (2025). Glucose Metabolism Modulation as a Strategy to Enhance Cancer Radiotherapy. Metabolites. 15(12). 793–793.
3.
Shen, Xiaolin, et al.. (2024). Composite catalyst regenerated from spent Cu-Bi-spinel adsorbent and its Fenton-like photocatalysis mechanism for efficient removal of sulfamethoxazole. Journal of environmental chemical engineering. 12(5). 113299–113299. 4 indexed citations
5.
Liu, Xiaochang, Xin Huang, Jinhua Luo, et al.. (2024). Low-dose radiation promotes high-fat diet-induced atherosclerosis by activating cGAS signal pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(7). 167443–167443. 1 indexed citations
6.
Zhong, Hua, Zhuozhuo Wang, Xiaochang Liu, et al.. (2024). Efficient adsorption removal of carbamazepine from water by dual-activator modified hydrochar. Separation and Purification Technology. 353. 128287–128287. 16 indexed citations
7.
Liu, Xiaochang, et al.. (2024). Secondary sclerosing cholangitis due to drug-induced liver injury: a retrospective cohort study. European Journal of Gastroenterology & Hepatology. 37(3). 343–349.
8.
Cui, Yufang, et al.. (2023). Natural Course of Common Bile Duct Microlithiasis. Digestive Diseases and Sciences. 68(11). 4252–4258. 1 indexed citations
9.
Zhang, Kai, Yanling Zhuang, Jiwen Li, Xiaochang Liu, & Shaoheng He. (2020). <p>Poly(Acrylic Acid)-Modified MoS<sub>2</sub> Nanoparticle-Based Transdermal Delivery of Atenolol</p>. International Journal of Nanomedicine. Volume 15. 5517–5526. 21 indexed citations
10.
Zhang, Kai, et al.. (2020). Functionalized MoS 2 -nanoparticles for transdermal drug delivery of atenolol. Drug Delivery. 27(1). 909–916. 24 indexed citations
11.
Li, Zeng, Xiaochang Liu, Rui Li, & Jun Chang. (2018). Reduction of Aβ Generation by Schisandrin B through Restraining Beta-Secretase 1 Transcription and Translation. Medical Science Monitor. 24. 1219–1224. 3 indexed citations
12.
Wei, Wei, et al.. (2018). TMEM9 mediates IL-6 and IL-1β secretion and is modulated by the Wnt pathway. International Immunopharmacology. 63. 253–260. 15 indexed citations
13.
Li, Xiaoli, et al.. (2018). Suspected drug-induced liver injury associated with iguratimod: a case report and review of the literature. BMC Gastroenterology. 18(1). 130–130. 12 indexed citations
14.
Liu, Xiaochang, Meiying Liu, Chao Liu, et al.. (2017). An insight into the molecular mechanism of the temporary enhancement effect of isopulegol decanoate on the skin. International Journal of Pharmaceutics. 529(1-2). 161–167. 10 indexed citations
15.
Li, Ning, Peng Quan, Xiaocao Wan, et al.. (2017). Mechanistic insights of the enhancement effect of sorbitan monooleate on olanzapine transdermal patch both in release and percutaneous absorption processes. European Journal of Pharmaceutical Sciences. 107. 138–147. 33 indexed citations
16.
Liu, Xiaochang, Peng Quan, Shanshan Li, et al.. (2017). Time dependence of the enhancement effect of chemical enhancers: Molecular mechanisms of enhancing kinetics. Journal of Controlled Release. 248. 33–44. 62 indexed citations
17.
Chen, Yang, Dongmei Cun, Peng Quan, et al.. (2014). Saturated Long-Chain Esters of Isopulegol as Novel Permeation Enhancers for Transdermal Drug Delivery. Pharmaceutical Research. 31(8). 1907–1918. 20 indexed citations
18.
Han, Liang, Qiao Mei, Jian Huang, et al.. (2012). Effects and mechanism of anti-tumor necrosis factor-α on intestinal permeability in dextran sulfate sodium induced colitis mice. Zhonghua xiaohua zazhi. 32(6). 389–394. 1 indexed citations
19.
Mei, Qiao, Lei Diao, Jianming Xu, Xiaochang Liu, & Juan Jin. (2011). A protective effect of melatonin on intestinal permeability is induced by diclofenac via regulation of mitochondrial function in mice. Acta Pharmacologica Sinica. 32(4). 495–502. 30 indexed citations
20.
Liu, Xiaochang, Qiao Mei, Jianming Xu, & Jing Hu. (2009). Balsalazine decreases intestinal mucosal permeability of dextran sulfate sodium-induced colitis in mice. Acta Pharmacologica Sinica. 30(7). 987–993. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026